Restoring balance
to the immune system

Image courtesy NIH

We are developing innovative cell therapies to treat patients suffering from a dysregulated immune system, including severe COVID-19.

Restore balance to the immune system

Overcome Conventional Cell Therapy Limitations

Our SBI-101 enables sustained, controlled dosage of MSC-secreted therapeutic molecules that are unattainable by direct injection or intravenous infusion.

What We Do
Transform cell therapy treatment

Realize the Vast Therapeutic Promise of MSCs

We are developing novel therapeutics for acute indications characterized by systemic inflammation, including COVID-19.

What We Do

Join Our Team

We are actively recruiting top scientific and commercial talent to join us on our quest to restore balance to the immune system and transform cell therapy treatment.